Research and Markets: Global Epilepsy Market 2014-2018: Reformulation of Marketed Drugs with GSK, Pfizer & UCB Dominating

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/c4q58n/global_epilepsy) has announced the addition of the "Global Epilepsy Market 2014-2018" report to their offering.

The Global Epilepsy market to grow at a CAGR of 5.06% over the period 2013-2018

Epilepsy is defined as a spectrum of brain disorders varying from benign symptoms to severe, disabling, and life-threatening symptoms. It can be caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as occurs in majority of the cases, it is known as idiopathic epilepsy. Epilepsy is characterized by repeated occurrence of generalized or focal seizures. Seizures result from an imbalance between the inhibitory and excitatory signals of the brain leading to sudden-onset of excitation. The occurrence of two or more unprovoked seizures is an important criteria to diagnose a person with seizures as being epileptic.

One key trend in this market is the reformulation of marketed drugs. Reformulated drugs, usually, have better tolerability and better dosing schedules than the original drugs. This increases the market acceptance of such drugs, driving their market revenue.

According to the report, unmet medical needs are one of the major drivers of the market. Lack of safe, efficacious, and disease-modifying treatment is a major unmet need. Currently, drugs administered for epilepsy are intended to treat seizures. However, they fail to check the progression of the disease.

Further, the report states that Generic erosion is one of the major challenges in the market. This, in turn, decreases the market revenue of individual drugs.

Key Vendors

  • GlaxoSmithKline
  • Pfizer
  • UCB

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Market Segmentation by Generation of Drugs
  8. Geographical Segmentation
  9. Buying Criteria
  10. Market Growth Drivers
  11. Drivers and their Impact
  12. Market Challenges
  13. Impact of Drivers and Challenges
  14. Market Trends
  15. Trends and their Impact
  16. Vendor Landscape
  17. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/c4q58n/global_epilepsy

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices